Feature | Artificial Intelligence | October 18, 2019 | Sanjay Parekh, Ph.D.

Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers

Artificial intelligence platforms and marketplaces, akin to mobile app stores, offer a unified approach to deploying AI in medical imaging

Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers

October 18, 2019 — As the nascent market for artificial intelligence (AI) in medical imaging develops, healthcare providers are faced with the question of how best to select, purchase and implement the rapidly expanding range of regulatory approved AI-enabled imaging applications and AI algorithms. More than 50 vendors have received regulatory clearance for medical imaging AI products and with more than 200 algorithm developers active in the market, product availability will increase many-fold in the coming years. Purchasing algorithms direct from multiple vendors adds an administrative overhead, not to mention the technical challenges of integrating these algorithms in existing systems and clinical workflows. AI platforms and marketplaces, akin to mobile app stores, offer a unified approach to deploying AI in medical imaging. A summary from Signify Research of the advantages and disadvantages for healthcare providers of AI marketplaces is provided below.

Advantages and disadvantages for healthcare provider of AI marketplaces

Signify Research graphic showing the advantages and disadvantages for healthcare providers of AI marketplaces.

The first marketplace/platform offerings entered the market in the last couple of years, and several new ones are expected to be announced at the 2019 annual meeting of the Radiological Society of North America (RSNA 2019). The performance and functionality of these solutions varies between vendors, with some offering what is essentially an online application store, with little or no support for integration, and others offering end-to-end solutions that address many of the engineering (deployment, workflow integration, etc.) and commercial (contracting, billing, etc.) challenges associated with the distribution and implementation of AI.

The following selection guide highlights some of the criteria that healthcare providers should consider when selecting a marketplace/platform vendor and compares six offerings from a selection of vendors from different parts of the world: Blackford Analysis (from the U.K.), Incepto (France), Nuance Healthcare (U.S.), Siemens Healthineers (Germany), TeraRecon (U.S.) and Wingspan (China). This selection guide is based on verified contributions from each of the vendors. Signify Research anticipates this will be a useful resource for healthcare providers when determining whether to implement a marketplace offering, and then, which vendor to select.

Access an expanded version of the chart here.

AI marketplaces with the most partners and greatest number of applications and algorithms may, at first sight, appear the obvious to partner with. However, healthcare providers are advised to consider how these will be implemented in clinical practice, and the level of contracting and technical support provided by the marketplace. The selection guide also covers a range of other criteria and functionalities that should be considered, and how today’s marketplaces perform against these criteria. For example, when considering workflow integration, providers are advised to consider: 

  • How images are routed to the AI; 

  • How algorithms/applications are prioritized; 

  • How the radiologist engages with the AI results; and 

  • How the results are populated in the radiologist report. 

Other considerations include deployment options (cloud or on-premise) and tools for clinicians to develop their own AI solutions.

This is the first edition of the selection guide and Signify Research intends to release regular updates as new marketplaces/platforms come to market. The next release is scheduled for shortly after RSNA 2019.

Editor’s note: Sanjay Parekh, Ph.D., is a senior market analyst with Signify Research. The firm is an independent supplier of market intelligence and consultancy to the global healthcare technology industry. Its major coverage areas are healthcare IT, medical imaging and digital health. Its clients include technology vendors, healthcare providers and payers, management consultants and investors. Signify Research is headquartered in Cranfield, U.K.

 

Related AI Marketplace Content:

How to Market Healthcare Artificial Intelligence Software

Nuance and Partners HealthCare Collaborate to Create AI Marketplace for Diagnostic Imaging

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018

TeraRecon Receives First-of-Kind FDA Determination for Northstar AI Results Explorer

Densitas Breast Density Assessment Software Joins Nuance AI Marketplace

VIDEO: The Economics of Artificial Intelligence — Interview with Khan Siddiqui, M.D.

How Artificial Intelligence Might Impact Radiology

Related Content

 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 
News | Enterprise Imaging | February 18, 2021
February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired...
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...
Radiology, radiation therapy, PACS, Enterprise image, X-ray, DR Systems, CT, MRI, contrast, ultrasound, VNA, product comparisons, comparison charts on ITN magazine.
Feature | February 17, 2021
Imaging Technology News (ITN) maintains more than 40
The British Institute of Radiology supports the proposal by AXREM that staff members from private suppliers who work shoulder to shoulder with National Health Service (NHS) staff in high-risk areas in hospitals should be recognised as frontline health and social care staff and prioritised for COVID-19 vaccination accordingly.

Getty Images

News | Coronavirus (COVID-19) | February 12, 2021
February 12, 2021 — The British Institute of Radiology supports the proposal by...
The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients
News | Artificial Intelligence | February 10, 2021
February 10, 2021 — Median Technologies announced the company has signed a research collaboration agreement with the
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.
Pexip, a leading provider of enterprise video conferencing and collaboration solutions, today announced a native integration with the electronic health record system, Epic.
News | Teleradiology | February 09, 2021
February 9, 2021 — ...
 Nuance Communications, Inc. announced the acquisition of Saykara, Inc., a like-minded startup focused on developing a mobile AI assistant to automate clinical documentation for physicians. The acquisition underscores Nuance's ongoing expansion of market and technical leadership in conversational artificial intelligence (AI) and ambient clinical intelligence (ACI) solutions that reduce clinician burnout, enhance patient experiences, and improve overall health system financial integrity.
News | Artificial Intelligence | February 08, 2021
February 8, 2021 — ...